Related Experiment Video
Updated: Dec 24, 2025

Cardiopulmonary Bypass in a Mouse Model: A Novel Approach
Published on: September 22, 2017
Rabbit models of heart disease
Steven M Pogwizd1, Donald M Bers2
1Departments of Medicine, Physiology, and Biophysics & Bioengineering, University of Alabama at Birmingham, Birmingham, AL, United States.
This review examines the use of rabbits as experimental subjects for studying human heart conditions. Because rabbit hearts share more physiological similarities with humans than smaller rodents do, they serve as a valuable middle ground for testing new medical treatments and understanding disease development.
Area of Science:
- Cardiovascular physiology research within Rabbit models of heart disease
- Translational medicine and comparative anatomy
Background:
No prior work had fully resolved the limitations of using small rodents to model human cardiac conditions. Researchers often struggle to translate findings from mice to clinical settings due to significant physiological disparities. That uncertainty drove the need for alternative animal systems that better mimic human heart function. It was already known that large mammals offer high fidelity but present substantial logistical and ethical challenges. This gap motivated the exploration of medium-sized species as a more practical experimental platform. Prior research has shown that rabbits possess cellular and molecular traits closely aligned with human cardiac biology. Such alignment suggests that these animals could bridge the gap between basic rodent studies and human clinical trials. Scientists continue to seek reliable systems that balance experimental feasibility with high translational relevance for cardiovascular medicine.
Purpose Of The Study:
The aim of this review is to evaluate the utility of rabbit models in understanding the etiology and mechanisms of human cardiac dysfunction. Researchers seek to address the limitations inherent in current small rodent models, which often fail to replicate human heart physiology accurately. This study explores how medium-sized animals can serve as a more effective bridge for translational research. The authors intend to provide a comprehensive overview of various induced cardiac conditions, including ischemia and drug-induced arrhythmias. They also examine the role of genetic manipulation and chemical induction in creating these experimental systems. By analyzing these diverse models, the team hopes to clarify their potential for testing novel therapeutic strategies. The motivation stems from the urgent need to reduce mortality and disability associated with heart disease. Ultimately, the work highlights why these specific animal systems are valuable for advancing clinical knowledge.
Main Methods:
Review approach involved a comprehensive synthesis of existing literature regarding various experimental cardiac platforms. The analysis focused on comparing physiological traits across different species to establish translational validity. Investigators examined documented protocols for inducing specific heart conditions in medium-sized animals. The study evaluated data derived from pressure overload, volume overload, and rapid-pacing techniques. Researchers also reviewed evidence concerning chemical-induced damage, such as doxorubicin toxicity and drug-induced arrhythmias. The team assessed the utility of transgenesis and infection-based models in replicating human pathology. This systematic evaluation prioritized studies that demonstrated molecular and cellular similarities to human cardiac tissue. The methodology emphasized the practical advantages of using rabbits over both small rodents and large mammals.
Main Results:
Key findings from the literature indicate that rabbit hearts possess cellular and molecular characteristics highly similar to human hearts. This similarity provides a distinct advantage over rodent models, where major physiological differences often complicate the translation of results. The review identifies multiple established rabbit models, including those for ischemia, pressure overload, and volume overload. Researchers report that these models are effective for studying the etiology and mechanisms of cardiac dysfunction. The literature confirms that rapid-pacing and drug-induced arrhythmia models are well-characterized within this species. Furthermore, the use of doxorubicin and transgenesis allows for precise investigation of specific molecular pathways. The data suggest that these models facilitate the assessment of novel therapeutic strategies. The synthesis shows that rabbits represent a practical and reliable alternative for cardiovascular research.
Conclusions:
The authors propose that rabbits serve as a highly relevant medium-sized platform for investigating complex cardiac pathologies. Synthesis and implications suggest that these models effectively bridge the translational divide between rodent studies and human clinical applications. Researchers indicate that the physiological alignment of rabbit hearts with human counterparts enhances the predictive value of experimental outcomes. The review highlights that various induced conditions, such as ischemia and drug-induced arrhythmias, provide robust frameworks for testing novel interventions. Authors note that these experimental systems facilitate the evaluation of therapeutic strategies that may eventually benefit human patients. The evidence supports the continued use of these animals to clarify the etiology of cardiac dysfunction. Investigators emphasize that the practical nature of this species offers a sustainable alternative to larger, more difficult-to-manage mammals. The findings confirm that rabbit models remain a vital tool for advancing our understanding of heart disease mechanisms.
Frequently Asked Questions
The researchers propose that rabbit models allow for the assessment of therapeutic strategies, such as those targeting ischemia or drug-induced arrhythmias, which may prove beneficial for humans. Unlike rodents, these animals exhibit cellular and molecular characteristics that closely mirror human cardiac physiology.
The authors discuss several specific experimental approaches, including pressure or volume overload, rapid-pacing, doxorubicin administration, and transgenesis. These techniques are used to induce various forms of cardiac dysfunction to study their underlying causes.
The researchers note that the rabbit is a medium-sized animal, making it a practical alternative to larger mammals like pigs or dogs. This size is necessary to balance the ease of handling with the requirement for physiological similarity to human hearts.
The authors explain that transgenesis is one of the methods used to create these models. This genetic tool allows for the specific manipulation of cardiac traits to study the molecular mechanisms of dysfunction.
The researchers observe that rodent hearts differ significantly from human hearts, which limits the extrapolation of results. In contrast, the rabbit heart displays molecular and cellular features that are much more similar to those found in human patients.
The authors imply that these models are essential for understanding the etiology of cardiac dysfunction. They suggest that using these animals will lead to more reliable data that can be translated into effective human therapies.

